Hepatocellular carcinoma

Mary Ann Huang, Jorge A. Marrero

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The number of papers published regarding hepatocellular carcinoma increased remarkably over the previous year. The 1-year survival for hepatocellular carcinoma has only improved slightly over the past 20 years, while the overall survival has remained unchanged. Hepatitis B genotypes, specifically genotype B, correlate with better response and survival in patients with hepatocellular carcinoma caused by this chronic infection. A consensus conference recommended that patients with Child-Turcotte-Pugh class A or B cirrhosis should be screened with ultrasound and α-fetoprotein measurement every 6 months. Using microarray technology, several groups established the gene expression for human hepatocellular carcinoma including the identification of potential genes involved in hepatic carcinogenesis. Dynamic gadolinium MRI is the preferred imaging of choice for the evaluation of hepatocellular carcinoma, but contrast-enhanced power Doppler ultrasound is a new imaging technique able to differentiate neoplastic from nonneoplastic liver lesions. Overall, transplantation is the best long-term therapeutic option, but in patients without portal hypertension and well-preserved liver function, resection may be preferable.

Original languageEnglish (US)
Pages (from-to)345-350
Number of pages6
JournalCurrent Opinion in Gastroenterology
Volume18
Issue number3
DOIs
StatePublished - 2002

Fingerprint

Hepatocellular Carcinoma
Survival
Liver
Genotype
Fetal Proteins
Doppler Ultrasonography
Gadolinium
Portal Hypertension
Hepatitis B
Carcinogenesis
Fibrosis
Transplantation
Technology
Gene Expression
Infection
Genes
Therapeutics

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Hepatocellular carcinoma. / Huang, Mary Ann; Marrero, Jorge A.

In: Current Opinion in Gastroenterology, Vol. 18, No. 3, 2002, p. 345-350.

Research output: Contribution to journalArticle

Huang, Mary Ann ; Marrero, Jorge A. / Hepatocellular carcinoma. In: Current Opinion in Gastroenterology. 2002 ; Vol. 18, No. 3. pp. 345-350.
@article{56f1c0cd051d40abb6aad06cafb05428,
title = "Hepatocellular carcinoma",
abstract = "The number of papers published regarding hepatocellular carcinoma increased remarkably over the previous year. The 1-year survival for hepatocellular carcinoma has only improved slightly over the past 20 years, while the overall survival has remained unchanged. Hepatitis B genotypes, specifically genotype B, correlate with better response and survival in patients with hepatocellular carcinoma caused by this chronic infection. A consensus conference recommended that patients with Child-Turcotte-Pugh class A or B cirrhosis should be screened with ultrasound and α-fetoprotein measurement every 6 months. Using microarray technology, several groups established the gene expression for human hepatocellular carcinoma including the identification of potential genes involved in hepatic carcinogenesis. Dynamic gadolinium MRI is the preferred imaging of choice for the evaluation of hepatocellular carcinoma, but contrast-enhanced power Doppler ultrasound is a new imaging technique able to differentiate neoplastic from nonneoplastic liver lesions. Overall, transplantation is the best long-term therapeutic option, but in patients without portal hypertension and well-preserved liver function, resection may be preferable.",
author = "Huang, {Mary Ann} and Marrero, {Jorge A.}",
year = "2002",
doi = "10.1097/00001574-200205000-00008",
language = "English (US)",
volume = "18",
pages = "345--350",
journal = "Current Opinion in Gastroenterology",
issn = "0267-1379",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Hepatocellular carcinoma

AU - Huang, Mary Ann

AU - Marrero, Jorge A.

PY - 2002

Y1 - 2002

N2 - The number of papers published regarding hepatocellular carcinoma increased remarkably over the previous year. The 1-year survival for hepatocellular carcinoma has only improved slightly over the past 20 years, while the overall survival has remained unchanged. Hepatitis B genotypes, specifically genotype B, correlate with better response and survival in patients with hepatocellular carcinoma caused by this chronic infection. A consensus conference recommended that patients with Child-Turcotte-Pugh class A or B cirrhosis should be screened with ultrasound and α-fetoprotein measurement every 6 months. Using microarray technology, several groups established the gene expression for human hepatocellular carcinoma including the identification of potential genes involved in hepatic carcinogenesis. Dynamic gadolinium MRI is the preferred imaging of choice for the evaluation of hepatocellular carcinoma, but contrast-enhanced power Doppler ultrasound is a new imaging technique able to differentiate neoplastic from nonneoplastic liver lesions. Overall, transplantation is the best long-term therapeutic option, but in patients without portal hypertension and well-preserved liver function, resection may be preferable.

AB - The number of papers published regarding hepatocellular carcinoma increased remarkably over the previous year. The 1-year survival for hepatocellular carcinoma has only improved slightly over the past 20 years, while the overall survival has remained unchanged. Hepatitis B genotypes, specifically genotype B, correlate with better response and survival in patients with hepatocellular carcinoma caused by this chronic infection. A consensus conference recommended that patients with Child-Turcotte-Pugh class A or B cirrhosis should be screened with ultrasound and α-fetoprotein measurement every 6 months. Using microarray technology, several groups established the gene expression for human hepatocellular carcinoma including the identification of potential genes involved in hepatic carcinogenesis. Dynamic gadolinium MRI is the preferred imaging of choice for the evaluation of hepatocellular carcinoma, but contrast-enhanced power Doppler ultrasound is a new imaging technique able to differentiate neoplastic from nonneoplastic liver lesions. Overall, transplantation is the best long-term therapeutic option, but in patients without portal hypertension and well-preserved liver function, resection may be preferable.

UR - http://www.scopus.com/inward/record.url?scp=0036224017&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036224017&partnerID=8YFLogxK

U2 - 10.1097/00001574-200205000-00008

DO - 10.1097/00001574-200205000-00008

M3 - Article

C2 - 17033305

AN - SCOPUS:0036224017

VL - 18

SP - 345

EP - 350

JO - Current Opinion in Gastroenterology

JF - Current Opinion in Gastroenterology

SN - 0267-1379

IS - 3

ER -